找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Challenges in Protein Product Development; Nicholas W. Warne,Hanns-Christian Mahler Book 2018 American Association of Pharmaceutical Scien

[复制链接]
楼主: 实体
发表于 2025-3-28 17:12:57 | 显示全部楼层
Analytical Characterization and Predictive Tools for Highly Concentrated Protein Formulationsion of predictive tools used during early development, specific challenges for analytical methods, and extended characterization of rheological and structural properties. The application of predictive tools during clinical lead selection and early-stage development helps to assess whether a selected
发表于 2025-3-28 19:22:39 | 显示全部楼层
Practical Considerations for High Concentration Protein Formulationsgh concentration protein formulations have an increased tendency for high solution viscosity, physical stability sensitivities (aggregation/particulation), and non-Newtonian solution behavior (shear thinning) due to high shear rates. Process unit operations can be negatively impacted by these factor
发表于 2025-3-29 02:57:00 | 显示全部楼层
发表于 2025-3-29 03:36:05 | 显示全部楼层
Development of Prefilled Syringe Combination Products for Biologicsther combination products offer patients the convenience of at-home self-administration. This can result in considerable cost savings compared to dosing in a clinical setting. PFS systems improve patient compliance and dosing accuracy, reduce overfill cost and waste, and can reduce sharps injuries (
发表于 2025-3-29 08:01:51 | 显示全部楼层
发表于 2025-3-29 13:32:22 | 显示全部楼层
C Mini-pumpseutics in combination with particular usability needs. Introductory Sect. . reflects on the growing requirements on drug delivery devices for biologics in connection with new indications and user groups. Section . discusses the boundary conditions, physical basics and technical requirements. Section
发表于 2025-3-29 16:15:43 | 显示全部楼层
Container Closure Integrity Testing of Primary Containers for Parenteral Productsntent inside. Ensuring the CCI of a parenteral product package is essential during the entire lifecycle of a product. The chapter first reviews the U.S. FDA regulatory requirements on CCI. Regulations for several regulatory authorities outside the USA are also presented for comparison. From these re
发表于 2025-3-29 20:16:17 | 显示全部楼层
发表于 2025-3-30 03:57:08 | 显示全部楼层
Foggingestricted to ion leaching or corrosion effects but also impacting adsorption phenomena. The formulation can creep up the walls forming a thin liquid layer on the inside of the containers. This layer is getting visible as product residues on the vial walls after a lyophilization process. This mechani
发表于 2025-3-30 06:38:06 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-26 23:03
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表